<?xml version="1.0" encoding="UTF-8" ?>
<oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>3D Printing of a Multi-Layered Polypill Containing Six Drugs Using a Novel Stereolithographic Method</dc:title>
<dc:creator>Robles Martínez, Pamela</dc:creator>
<dc:creator>Xu, Xiaoyan</dc:creator>
<dc:creator>Trenfield, Sarah J.</dc:creator>
<dc:creator>Awad, Atheer</dc:creator>
<dc:creator>Goyanes Goyanes, Álvaro</dc:creator>
<dc:creator>Telford, Richard</dc:creator>
<dc:creator>Basit, Abdul W.</dc:creator>
<dc:creator>Gaisford, Simon</dc:creator>
<dc:contributor>Universidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica</dc:contributor>
<dc:subject>Three-dimensional printing</dc:subject>
<dc:subject>Additive manufacturing</dc:subject>
<dc:subject>Printlets</dc:subject>
<dc:subject>Tablets</dc:subject>
<dc:subject>Personalized medicines</dc:subject>
<dc:subject>Multiple-layer dosage forms</dc:subject>
<dc:subject>Stereolithography</dc:subject>
<dc:subject>Vat polymerisation</dc:subject>
<dc:description>Three-dimensional printing (3DP) has demonstrated great potential for multi-material fabrication because of its capability for printing bespoke and spatially separated material conformations. Such a concept could revolutionise the pharmaceutical industry, enabling the production of personalised, multi-layered drug products on demand. Here, we developed a novel stereolithographic (SLA) 3D printing method that, for the first time, can be used to fabricate multi-layer constructs (polypills) with variable drug content and/or shape. Using this technique, six drugs, including paracetamol, caffeine, naproxen, chloramphenicol, prednisolone and aspirin, were printed with different geometries and material compositions. Drug distribution was visualised using Raman microscopy, which showed that whilst separate layers were successfully printed, several of the drugs diffused across the layers depending on their amorphous or crystalline phase. The printed constructs demonstrated excellent physical properties and the different material inclusions enabled distinct drug release profiles of the six actives within dissolution tests. For the first time, this paper demonstrates the feasibility of SLA printing as an innovative platform for multi-drug therapy production, facilitating a new era of personalised polypills</dc:description>
<dc:description>The authors thank the Engineering and Physical Sciences Research Council (EPSRC), UK for their financial support (EP/L01646X)</dc:description>
<dc:description>SI</dc:description>
<dc:date>2020-04-13T20:57:00Z</dc:date>
<dc:date>2020-04-13T20:57:00Z</dc:date>
<dc:date>2019</dc:date>
<dc:type>journal article</dc:type>
<dc:type>VoR</dc:type>
<dc:identifier>Robles-Martinez, P.; Xu, X.; Trenfield, S.J.; Awad, A.; Goyanes, A.; Telford, R.; Basit, A.W.; Gaisford, S. 3D Printing of a Multi-Layered Polypill Containing Six Drugs Using a Novel Stereolithographic Method. Pharmaceutics 2019, 11, 274</dc:identifier>
<dc:identifier>http://hdl.handle.net/10347/21335</dc:identifier>
<dc:identifier>10.3390/pharmaceutics11060274</dc:identifier>
<dc:identifier>1999-4923</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>https://doi.org/10.3390/pharmaceutics11060274</dc:relation>
<dc:rights>© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)</dc:rights>
<dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>open access</dc:rights>
<dc:publisher>MDPI</dc:publisher>
</oai_dc:dc>
<?xml version="1.0" encoding="UTF-8" ?>
<record schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<leader>00925njm 22002777a 4500</leader>
<datafield ind1=" " ind2=" " tag="042">
<subfield code="a">dc</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Robles Martínez, Pamela</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Xu, Xiaoyan</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Trenfield, Sarah J.</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Awad, Atheer</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Goyanes Goyanes, Álvaro</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Telford, Richard</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Basit, Abdul W.</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Gaisford, Simon</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="260">
<subfield code="c">2019</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="520">
<subfield code="a">Three-dimensional printing (3DP) has demonstrated great potential for multi-material fabrication because of its capability for printing bespoke and spatially separated material conformations. Such a concept could revolutionise the pharmaceutical industry, enabling the production of personalised, multi-layered drug products on demand. Here, we developed a novel stereolithographic (SLA) 3D printing method that, for the first time, can be used to fabricate multi-layer constructs (polypills) with variable drug content and/or shape. Using this technique, six drugs, including paracetamol, caffeine, naproxen, chloramphenicol, prednisolone and aspirin, were printed with different geometries and material compositions. Drug distribution was visualised using Raman microscopy, which showed that whilst separate layers were successfully printed, several of the drugs diffused across the layers depending on their amorphous or crystalline phase. The printed constructs demonstrated excellent physical properties and the different material inclusions enabled distinct drug release profiles of the six actives within dissolution tests. For the first time, this paper demonstrates the feasibility of SLA printing as an innovative platform for multi-drug therapy production, facilitating a new era of personalised polypills</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">Robles-Martinez, P.; Xu, X.; Trenfield, S.J.; Awad, A.; Goyanes, A.; Telford, R.; Basit, A.W.; Gaisford, S. 3D Printing of a Multi-Layered Polypill Containing Six Drugs Using a Novel Stereolithographic Method. Pharmaceutics 2019, 11, 274</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">http://hdl.handle.net/10347/21335</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">10.3390/pharmaceutics11060274</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">1999-4923</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Three-dimensional printing</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Additive manufacturing</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Printlets</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Tablets</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Personalized medicines</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Multiple-layer dosage forms</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Stereolithography</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Vat polymerisation</subfield>
</datafield>
<datafield ind1="0" ind2="0" tag="245">
<subfield code="a">3D Printing of a Multi-Layered Polypill Containing Six Drugs Using a Novel Stereolithographic Method</subfield>
</datafield>
</record>